Characteristics of adverse events of endocrine therapies among older patients with breast cancer
Author:
Funder
MEXT/JSPS KAKENHI
The Japanese Foundation for Multidisciplinary Treatment of Cancer
Publisher
Springer Science and Business Media LLC
Subject
Oncology
Link
http://link.springer.com/article/10.1007/s00520-019-04674-8/fulltext.html
Reference36 articles.
1. Miller WR, Hawkins RA, Forrest AP (1982) Significance of aromatase activity in human breast cancer. Cancer Res 42:3365s–3368s
2. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG), Dowsett M, Forbes JF, Bradley R, Ingle J, Aihara T, Bliss J, Boccardo F, Coates A, Coombes RC, Cuzick J, Dubsky P, Gnant M, Kaufmann M, Kilburn L, Perrone F, Rea D, Thurlimann B, van de Velde C, Pan H, Peto R, Davies C, Gray R (2015) Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet 386:1341–1352
3. Honma N, Hosoi T, Arai T, Takubo K (2015) Estrogen and cancers of the colorectum, breast, and lung in postmenopausal women. Pathol Int 65:451–459
4. Kennelly R, Kavanagh DO, Hogan AM, Winter DC (2008) Oestrogen and the colon: potential mechanisms for cancer prevention. Lancet Oncol 9:385–391
5. Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC (1976) Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet 1:1038–1041
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PERCEIVED EXERCISE BELIEFS AND BARRIERS AMONG BREAST CANCER SURVIVORS: A DESCRIPTIVE CROSS-SECTIONAL STUDY;Sağlık Bilimleri Dergisi;2024-07-25
2. An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients;Current Oncology Reports;2024-02-24
3. Current and future advances in practice: aromatase inhibitor–induced arthralgia;Rheumatology Advances in Practice;2024-01-01
4. Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer;Frontiers in Oncology;2022-12-12
5. Metastatic or suspected metastatic cancer in patients 90 years of age or older: A single-institution, multi-site study;Journal of Geriatric Oncology;2021-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3